VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Eltrombopag for aplastic anaemia in Europe

Régis Peffault de Latour, MD, PhD, Saint-Louis Hospital, Paris, France, discusses the Severe Aplastic Anemia Working Party (SAA-WP) guidelines on the use of eltrombopag, in aplastic anemia patients in Europe. Dr de Latour also touches on the RACE trial (NCT02099747), a multicenter study comparing horse antithymocyte globulin and cyclosporine A with or without eltrombopag as front-line therapy for severe aplastic anemia patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter